Parameters | NCEP ATP3 2005* | IDF 2009 | EGIR 1999 | WHO 1999 | AACE 2003 |
Required | Insulin resistance or fasting hyperinsulinemia (ie, in top 25% of the laboratory-specific reference range) | Insulin resistance in top 25%Δ; fasting glucose ≥6.1 mmol/L (110 mg/dL); 2-hour glucose ≥7.8 mmol/L (140 mg/dL) | High risk of insulin resistance◊ or BMI ≥25 kg/m2 or waist ≥102 cm (men) or ≥88 cm (women) | ||
Number of abnormalities | ≥3 of: | ≥3 of: | And ≥2 of: | And ≥2 of: | And ≥2 of: |
Glucose | Fasting glucose ≥5.6 mmol/L (100 mg/dL) or drug treatment for elevated blood glucose | Fasting glucose ≥5.6 mmol/L (100 mg/dL) or diagnosed diabetes | Fasting glucose 6.1 to 6.9 mmol/L (110 to 125 mg/dL) | Fasting glucose ≥6.1 mmol/L (110 mg/dL); ≥2-hour glucose 7.8 mmol/L (140 mg/dL) | |
HDL cholesterol | <1.0 mmol/L (40 mg/dL) (men); <1.3 mmol/L (50 mg/dL) (women) or drug treatment for low HDL cholesterol§ | <1.0 mmol/L (40 mg/dL) (men); <1.3 mmol/L (50 mg/dL) (women) or drug treatment for low HDL cholesterol | <1.0 mmol/L (40 mg/dL) | <0.9 mmol/L (35 mg/dL) (men); <1.0 mmol/L (40 mg/dL) (women) | <1.0 mmol/L (40 mg/dL) (men); <1.3 mmol/L (50 mg/dL) (women) |
Triglycerides | ≥1.7 mmol/L (150 mg/dL) or drug treatment for elevated triglycerides§ | ≥1.7 mmol/L (150 mg/dL) or drug treatment for high triglycerides | or ≥2.0 mmol/L (180 mg/dL) or drug treatment for dyslipidemia | or ≥1.7 mmol/L (150 mg/dL) | ≥1.7 mmol/L (150 mg/dL) |
Obesity | Waist ≥102 cm (men) or ≥88 cm (women)¥ | Waist ≥94 cm (men) or ≥80 cm (women) | Waist ≥94 cm (men) or ≥80 cm (women) | Waist/hip ratio >0.9 (men) or >0.85 (women) or BMI ≥30 kg/m2 | |
Hypertension | ≥130/85 mmHg or drug treatment for hypertension | ≥130/85 mmHg or drug treatment for hypertension | ≥140/90 mmHg or drug treatment for hypertension | ≥140/90 mmHg | ≥130/85 mmHg |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟